C&R Research Inc., Korea’s leading
contract research organization (CRO), has launched its major global initiative
by establishing C&R Healthcare Global Pte. Ltd., a subsidiary company
specialized in promoting global business partnerships and securing investments.
The initiative will facilitate licensing, strategic partnerships and investment
opportunities for promising bio-pharmaceutical companies based in Korea.
C&R Research has partnered with Korea’s
health and medical industries in clinical development for the past 20 years
since its foundation in 1997. To date, C&R Research has carried out a total
of 1,200 clinical trials, coupled with drug license services, thus emerging as
Asia’s representative CRO beyond Korea.
On October 13th, 2017, C&R Healthcare
Global completed a MOU with W Medical Strategy Group, a New York based
consulting firm with diverse medical and pharmaceutical networking portfolio,
to further explore global strategic partnerships.
Under the new partnership, W Medical Strategy
Group supports global outreach of C&R Research and provides strategic
consulting to provide an essential bridgehead in North America for Korean
bio-pharmaceutical industry.
C&R Healthcare Global provides service to
biohealth companies and recruits companies to move into Singapore Incubating
Center. Detailed information can be found at C&R Healthcare Global official
webpage at www.cnrhg.asia.